• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Derms protest planned FDA ban

Article

Schaumburg, Ill. - The American Academy of Dermatology (AAD) will object to a proposed federal ban of over-the-counter sales of hydroquinone.

Schaumburg, Ill. - The American Academy of Dermatology (AAD) will object to a proposed federal ban of over-the-counter sales of hydroquinone.

The Food and Drug Administration (FDA) has declared that products containing the bleaching agent pose risks of cancer and skin discoloration, and has proposed a ban on nonprescription sales.

If the agent is banned, all existing cosmetic products containing hydroquinone would need to submit a new drug application for the FDA's review, according to news reports.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.